DIA-US FDA Biosimilars Workshop “Navigating Biosimilars: FDA Insights On Development And Lifecycle Management Strategies”

We regret to inform you that the DIA-FDA Biosimilars Workshop scheduled for February 3-4, 2025, in Hyderabad, has been postponed until further notice. This decision follows the U.S. Administration's directive for the FDA to temporarily halt all travel and participation in external meetings. We sincerely apologize for any inconvenience caused and will provide updates as soon as they become available. Thank you for your understanding.

Back to Agenda

Session 5: Chemistry, Manufacturing, and Controls (CMC)

Speaker(s)

Dr. Kristen Nickens

US FDA, United States

Product Quality Team Lead, Office of Product Quality Assessment III, OPQ, CDER